Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease

Journal of Pathology

Volumn 191, Issue 2, 2000, Pages 202-207

  Geiger, R ^a   Berger, R M F ^a   Hess, J ^a   Bogers, A J J C ^a   Sharma, H S ^a   Mooi, W J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Congenital heart disease; Immunohistochemistry; Pulmonary hypertension; Pulmonary plexogenic arteriopathy; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ARTERY DISEASE; ARTICLE; CELL PROLIFERATION; CONGENITAL HEART DISEASE; ENDOTHELIUM CELL; HEART CATHETERIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG BLOOD FLOW; OPEN LUNG BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; TUMOR VOLUME;

CHILD; CHILD, PRESCHOOL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HEART DEFECTS, CONGENITAL; HEMODYNAMIC PROCESSES; HUMANS; LYMPHOKINES; MALE; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; PULMONARY ARTERY; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034039949     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200006)191:2<202::AID-PATH608>3.0.CO;2-D     Document Type: Article

References (23)

1. Wagenvoort CA. Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest 1980; 77: 614-625.
2. Haworth SG. Pulmonary hypertension in childhood. Eur Respir J 1993; 6: 1037-1041
3. Wagenvoort CA, Heath D, Edwards JE. The Pathology of the Pulmonary Vasculature. Thomas: Springfield, 1964; 302-304.
4. Haworth SG. Pulmonary vascular disease in different types of congenital heart disease. Implications for interpretation of lung biopsy findings in early childhood. Br Heart J 1984; 52: 559-571.
5. Wagenvoort CA. Open lung biopsies in congenital heart disease for evaluation of pulmonary vascular disease. Predictive value with regard to corrective operability. Histopathology 1985; 9: 417-436.
6. Hatano S, Strasser T (eds). Primary Pulmonary Hypertension. Report of Committee. World Health Organization: Geneva, 1975.
7. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-32.
8. Voelkel NF, Hoeper M, Maloney J, Tuder RM. Vascular endothelial growth factor in pulmonary hypertension. Ann N Y Acad Sci 1996; 31: 186-193.
9. Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994; 144: 275-285.
10. Yaginuma G, Mohn H, Takahashi T. Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease: a computer aided reconstruction study. Thorax 1990; 45: 586-590.
11. Wagenvoort CA, Mooi WJ. Biopsy Pathology of the Pulmonary Vasculature. Chapman & Hall: London, 1989.
12. Kliffen M, Sharma HS, Mooij CM, Kerkvliet S, de Jong PT. Increased expression of angiogenic growth factors in age-related maeulopathy. Br J Ophthalmol 1997; 81: 154-162.
13. Tuder RM, Badesch DB, Groves B, Lynch DA, Voelkel NF. Vascular permeability/growth factor expression in plexogenic pulmonary hypertension. J Cell Biochem Suppl 1994; 18: 330 (Abstract).
14. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J Clin Invest 1995; 95: 1798-1807.
15. Wagenvoort CA. Morphological substrate for the reversibilty and irreversibility of pulmonary hypertension. Eur Heart J 1989; 9 (Suppl J): 7-12.
16. Shifren JL, Doldi N, Ferrara N, Mesiano S, Jaffee RB. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J Clin Endocrinol Metab 1994; 79: 316-322.
17. Wagenvoort CA, Mooi WJ. Vascular diseases. In Pulmonary Pathology (2nd edn), Dail DH, Hammar SP (eds). Springer-Verlag: New York, 1994; 985-1025.
18. Yaginuma G, Mohri H, Takahashi T. Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease: a computer-aided reconstruction study. Thorax 1990; 45: 586-590.
19. Rabinovitch M, Bothwell T, Hayakawa BN, et al. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. Lab Invest 1986; 55: 632-653.
20. Resnick N, Gimbrone MA. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J 1995; 9: 874-882.
21. Karino T, Kwong HHM, Goldsmith HL. Particle flow in models of branching vessels: I. Vortices in 90 T-junctions. Biorheology 1979; 16: 231-248.
22. Asukara T, Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res 1990; 66: 1045-1066.
23. Davies P. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995; 75: 519-560.